Radar Telegram alerts Open Radar

Can Parkinson's disease be treated? Dopamine neuron transplantation performed for the first time in Japan. The country has entered a new phase of testing cell therapy against Parkinson's disease. At Kyoto University Hospital, study participants are being treated with dopamine neuron precursors derived from donor stem cells. Sumitomo Pharma noted that the method received conditional approval in the country in March 2026. This year, surgeons will perform no more than two such procedures, but by 2028 the number will rise to 20. Upon completion of the fourth phase of clinical trials, the innovative treatment will be available to a wider range of patients in various medical centers. Follow Max I Feedback

תרגם לעברית

360.ru · · Source

🇯🇵 Japan · Map

Can Parkinson's disease be treated? Dopamine neuron transplantation performed for the first time in Japan. The country has entered a new phase of testing cell therapy against Parkinson's disease. At Kyoto University Hospital, study participants are being treated with dopamine neuron precursors derived from donor stem cells. Sumitomo Pharma noted that the method received conditional approval in the country in March 2026. This year, surgeons will perform no more than two such procedures, but by 2028 the number will rise to 20. Upon completion of the fourth phase of clinical trials, the innovative treatment will be available to a wider range of patients in various medical centers. Follow Max I Feedback

Can Parkinson's disease be treated? Dopamine neuron transplantation performed for the first time in Japan. The country has entered a new phase of testing cell therapy against Parkinson's disease. At Kyoto University Hospital, study participants are being treated with dopamine neuron precursors derived from donor stem cells. Sumitomo Pharma noted that the method received conditional approval in the country in March 2026. This year, surgeons will perform no more than two such procedures, but by 2028 the number will rise to 20. Upon completion of the fourth phase of clinical trials, the innovative treatment will be available to a wider range of patients in various medical centers. Follow Max I Feedback

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram